TGFB1 and neoplasm: In the quadruple-mutant mice model bearing metastatic intestinal tumors with TGFβ-activated stroma, inhibition of TGFβ prevented metastasis by enhancing cytotoxic T-cell response against tumor cells, while the use of anti-PD1 drug drew finite efficacy.